Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Dive Brief: Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily caused by metastatic colorectal cancer.
Dive Brief: Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily caused by metastatic colorectal cancer.
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Identifeye Health, a startup looking to make
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Sequel Medtech is working to sell a
Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled
As the U.S. presidential election looms, a final group of medtech companies will report earnings results, setting the tone for the remainder of the year.
Medtronic settled a lawsuit claiming its pulse oximeters may provide less accurate readings for people with darker skin pigmentation. Roots Community Health, based in Oakland,
Larry Jones, Johnson & Johnson Medtech’s chief information officer, will resign after more than three decades with the company. “To my friends and partners throughout
Michelle Tarver, the new leader of the Food and Drug Administration’s medical device center, faces significant challenges ahead. Tarver is taking over as director of
By the numbers 11.9% increase year over year Stryker Q3 net earnings: $834 million 20.5% increase year over year 4% increase year over year Zimmer
Boston Scientific will close Silk Road Medical’s headquarters in Sunnyvale, California, after it bought the maker of stroke prevention products in September. Spokesperson Chanel Hastings